The interpretation of coffee's protective effects against atrial fibrillation may be fundamentally flawed due to a critical methodological oversight in recent research design. Rather than demonstrating coffee's antiarrhythmic properties, studies may inadvertently be measuring the harmful cardiovascular effects of caffeine withdrawal in habitual users. This methodological concern emerged from analysis of a recent interventional trial that examined AF recurrence after electrical cardioversion. The study design required regular coffee drinkers to abstain from their usual consumption, creating two distinct physiological states: maintained caffeine intake versus acute withdrawal. The observed reduction in AF recurrence among continued coffee consumers could reflect either genuine cardioprotective mechanisms or the destabilizing effects of caffeine cessation in the abstinence group. Caffeine withdrawal triggers a cascade of physiological changes including altered autonomic nervous system activity, modified adenosine receptor function, and potential inflammatory responses—all factors that could independently increase arrhythmia susceptibility. This distinction carries profound implications for clinical guidance and public health recommendations. If withdrawal effects drive the observed differences, then coffee's apparent benefits may be illusory, existing only in comparison to the artificially elevated risk created by cessation. The finding underscores a broader challenge in nutritional cardiology research: distinguishing between true therapeutic effects and the consequences of removing established dietary patterns. Future investigations should compare coffee consumption against true baseline states rather than withdrawal conditions, potentially requiring studies in caffeine-naive populations or longer adaptation periods to establish genuine physiological equilibrium.